Course Outcome:
CO1: Explain the fundamental properties of different stem cell types and their roles in regenerative medicine.
CO2: Describe the sources, isolation techniques, and characterization methods used in stem cell research and therapy.
CO3: Evaluate the clinical applications of stem cell therapies across various disease conditions using case studies and trial data.
CO4: Interpret the translational steps from preclinical studies to clinical implementation, including safety and delivery considerations.
CO5: Analyze the ethical, legal, and technical challenges associated with the development and application of stem cell-based therapies.
CO6: Discuss the regulatory frameworks and recent innovations shaping the future of stem cell therapies.
Program outcome
PO1: Bioscience Knowledge
PO2: Problem Analysis
PO3: Design/Development of Solutions
PO4: Conduct Investigations of complex problems
PO5: Modern tools usage
PO6: Bioscientist and Society
PO7: Environment and Sustainability
PO8: Ethics
PO9: Individual & Team work
PO10: Communication
PO11: Project management & Finance
PO12: Lifelong learning
0 – No affinity; 1 – low affinity; 2 – Medium affinity; 3 – High affinity
CO |
PO1 |
PO2 |
PO3 |
PO4 |
PO5 |
PO6 |
PO7 |
PO8 |
PO9 |
PO10 |
PO11 |
PO12 |
CO1 |
3 |
2 |
2 |
2 |
2 |
2 |
1 |
2 |
2 |
2 |
1 |
3 |
CO2 |
3 |
2 |
3 |
2 |
3 |
2 |
1 |
2 |
2 |
2 |
1 |
3 |
CO3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
2 |
2 |
2 |
2 |
3 |
CO4 |
3 |
3 |
3 |
3 |
3 |
2 |
2 |
2 |
2 |
2 |
2 |
3 |
CO5 |
3 |
2 |
2 |
2 |
2 |
3 |
2 |
3 |
2 |
2 |
2 |
3 |
CO6 |
3 |
2 |
2 |
2 |
2 |
3 |
2 |
3 |
2 |
2 |
2 |
3 |
Program-specific outcome
PSO 1 – Emerging technologies in cell therapy
PSO 2 – Biomolecules in Medicine
PSO 3 – Molecular dysregulation in diseases
PSO 4 – Molecular technology in diagnosis and therapy
PSO 5 – Applying lab discoveries to clinical practice
PSO 6 – Advanced techniques in cell culture, gene editing, and bioprocessing
PSO 7 – Statistical methods to interpret and validate diagnostic results
PSO 8 – Integrate cell therapy into personalized medicine
PSO 9 – GMP and regulatory practices in cell therapy production
PSO 10 – Bioinformatics and biological data use
0 – No affinity; 1 – low affinity; 2 – Medium affinity; 3 – High affinity
CO |
PSO1 |
PSO2 |
PSO3 |
PSO4 |
PSO5 |
PSO6 |
PSO7 |
PSO8 |
PSO9 |
PSO10 |
CO1 |
3 |
2 |
2 |
2 |
2 |
2 |
1 |
2 |
2 |
2 |
CO2 |
3 |
2 |
2 |
2 |
3 |
3 |
1 |
2 |
2 |
2 |
CO3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
2 |
2 |
CO4 |
3 |
2 |
2 |
2 |
3 |
2 |
2 |
3 |
2 |
2 |
CO5 |
3 |
2 |
2 |
2 |
2 |
2 |
2 |
3 |
2 |
2 |
CO6 |
3 |
2 |
2 |
2 |
2 |
2 |
2 |
3 |
3 |
2 |